OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PLSN57

Polson Ltd

Commodity ChemicalsVerified

Polson Limited's capital structure is characterized by a debt-to-equity ratio of 0.34, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.34, suggesting it can cover its short-term obligations but with limited buffer. Free cash flow is negative at -98.81 million INR, primarily due to capital expenditures of -211.68 million INR, which may signal ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 4.13% and a return on assets (ROA) of 2.77%, both below the industry median for Commodity Chemicals. The operating margin is 9.46% (88.24 million INR operating income on 932.81 million INR revenue), which is also below the industry median. This suggests that Polson Limited is underperforming in terms of profitability relative to its peers. The company's revenue is concentrated in a single business segment focused on synthetic and natural tanning substances, with no disclosed geographic diversification. This concentration increases exposure to sector-specific risks and regional economic fluctuations. The lack of segment or geographic breakdown in the financial data limits the ability to assess diversification benefits. Growth trajectory is constrained by the negative free cash flow and the absence of disclosed revenue growth in the outlook. The company's operating cash flow of 171.99 million INR is insufficient to cover capital expenditures, indicating a reliance on external financing or asset sales to fund expansion. The outlook for the current fiscal year does not include a projected revenue increase, and no specific growth drivers are identified in the provided data. Risk factors include medium liquidity risk due to the current ratio and negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. However, the negative free cash flow and capital expenditures may necessitate future financing, which could introduce dilution risk if not funded through operational cash flow. Recent events include the company's ongoing operations in Kolhapur, Maharashtra, and its focus on both synthetic and natural tanning substances. No recent filings or transcripts are provided in the input data to indicate strategic shifts or operational changes. The company's business model remains centered on manufacturing and exporting leather chemicals, with no disclosed innovation or expansion into new markets.

30-day price · PLSN+1594.00 (+15.9%)
Low$10006.00High$12370.00Close$11600.00As of17 May, 00:00 UTC
Profile
CompanyPolson Ltd
TickerPLSN.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Polson Limited is an India-based company engaged in the manufacturing and sale of synthetic organic tanning substances and natural-based vegetable tannin extracts for domestic and export markets.

Classification. Polson Limited is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Polson Limited's capital structure is characterized by a debt-to-equity ratio of 0.34, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.34, suggesting it can cover its short-term obligations but with limited buffer. Free cash flow is negative at -98.81 million INR, primarily due to capital expenditures of -211.68 million INR, which may signal ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 4.13% and a return on assets (ROA) of 2.77%, both below the industry median for Commodity Chemicals. The operating margin is 9.46% (88.24 million INR operating income on 932.81 million INR revenue), which is also below the industry median. This suggests that Polson Limited is underperforming in terms of profitability relative to its peers. The company's revenue is concentrated in a single business segment focused on synthetic and natural tanning substances, with no disclosed geographic diversification. This concentration increases exposure to sector-specific risks and regional economic fluctuations. The lack of segment or geographic breakdown in the financial data limits the ability to assess diversification benefits. Growth trajectory is constrained by the negative free cash flow and the absence of disclosed revenue growth in the outlook. The company's operating cash flow of 171.99 million INR is insufficient to cover capital expenditures, indicating a reliance on external financing or asset sales to fund expansion. The outlook for the current fiscal year does not include a projected revenue increase, and no specific growth drivers are identified in the provided data. Risk factors include medium liquidity risk due to the current ratio and negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. However, the negative free cash flow and capital expenditures may necessitate future financing, which could introduce dilution risk if not funded through operational cash flow. Recent events include the company's ongoing operations in Kolhapur, Maharashtra, and its focus on both synthetic and natural tanning substances. No recent filings or transcripts are provided in the input data to indicate strategic shifts or operational changes. The company's business model remains centered on manufacturing and exporting leather chemicals, with no disclosed innovation or expansion into new markets.
Key takeaways
  • Polson Limited has a conservative debt-to-equity ratio of 0.34, indicating a relatively low leverage position.
  • The company's ROE of 4.13% and ROA of 2.77% are below the industry median, suggesting underperformance in profitability.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Free cash flow is negative, and capital expenditures are high, indicating a need for external financing.
  • Liquidity risk is medium, and the company has a current ratio of 1.34, which is adequate but not robust.
  • No recent strategic or operational changes are disclosed, and the company's growth trajectory is constrained.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$932.8M
Gross profit$429.8M
Operating income$88.2M
Net income$52.3M
R&D
SG&A
D&A
SBC
Operating cash flow$172.0M
CapEx-$211.7M
Free cash flow-$98.8M
Total assets$1.89B
Total liabilities$620.9M
Total equity$1.27B
Cash & equivalents
Long-term debt$429.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.27B
Net cash-$429.1M
Current ratio1.3
Debt/Equity0.3
ROA2.8%
ROE4.1%
Cash conversion3.3%
CapEx/Revenue-22.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricPLSNActivity
Op margin9.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin5.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin46.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-22.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity34.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:18 UTC#40d13252
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:20 UTCJob: 0c34fb4f